Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics

por Karachaliou N, Rosell R
Publicado 2014

Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy

por Santarpia M, Liguori A, Karachaliou N, Gonzalez-Cao M, Daffinà MG, D'Aveni A, Marabello G, Altavilla G, Rosell R
Publicado 2017

Targeting PD-1/PD-L1 in lung cancer: current perspectives

por González-Cao M, Karachaliou N, Viteri S, Morales-Espinosa D, Teixidó C, Sánchez Ruiz J, Molina-Vila MÁ, Santarpia M, Rosell R
Publicado 2015